Literature DB >> 3348741

Cost of treating advanced leg ischemia. Bypass graft vs primary amputation.

C A Raviola1, L S Nichter, J D Baker, R W Busuttil, H I Machleder, W S Moore.   

Abstract

We compared the hospital costs of 94 patients undergoing femoropopliteal bypass grafts with those of 53 patients undergoing primary amputation. The total cost of uncomplicated bypass surgery averaged +20,300, compared with +14,000 for uncomplicated below-knee amputation. However, including the cost of prosthesis and rehabilitation, the total cost of primary amputation was +20,400, equivalent to that of the bypass operation. Complications requiring revision of a bypass graft increased hospitalization by 4.5 days with the total cost rising to +28,700; complications that ended with major amputation added 15 hospitalization days and had an average cost of +42,200. In contrast, complicated below-knee amputation cost +40,600 and added 12.5 hospitalization days. There is therefore no cost-benefit in primary amputation when compared with arterial reconstruction, and cost should not be used to deny a patient the opportunity for limb salvage.

Entities:  

Mesh:

Year:  1988        PMID: 3348741     DOI: 10.1001/archsurg.1988.01400280105021

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  3 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

2.  Popliteo-pedal bypass surgery for critical limb ischemia.

Authors:  D W Good; Hasan Al Chalabi; H Al Chalabi; F Hameed; B Egan; S Tierney; T M Feeley
Journal:  Ir J Med Sci       Date:  2011-07-29       Impact factor: 1.568

3.  Process of care and outcomes in patients with peripheral arterial disease.

Authors:  Tracie C Collins; Rebecca J Beyth; David B Nelson; Nancy J Petersen; Maria E Suarez-Almazor; Ruth L Bush; Alan T Hirsch; Carol M Ashton
Journal:  J Gen Intern Med       Date:  2007-04-24       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.